Literature DB >> 20839317

Effect of cell number on mesenchymal stem cell transplantation in a canine disc degeneration model.

Kenji Serigano1, Daisuke Sakai, Akihiko Hiyama, Futoshi Tamura, Masahiro Tanaka, Joji Mochida.   

Abstract

Transplantation of mesenchymal stem cells (MSCs) inhibits the progression of disc degeneration in animal models. We know of no study to determine the optimal number of cells to transplant into the degenerated intervertebral disc (IVD). To determine the optimal donor cell number for maximum benefit, we conducted an in vivo study using a canine disc degeneration model. Autologous MSCs were transplanted into degenerative discs at 10(5), 10(6), or 10(7) cells per disc. The MSC-transplanted discs were evaluated for 12 weeks using plain radiography, magnetic resonance imaging, and gross and microscopic evaluation. Preservation of the disc height, annular structure was seen in MSC-transplantation groups compared to the operated control group with no MSC transplantation. Result of the number of remaining transplanted MSCs, the survival rate of NP cells, and apoptosis of NP cells in transplanted discs showed both structural microenvironment and abundant extracellular matrix maintained in 10(6) MSCs transplanted disc, while less viable cells were detected in 10(5) MSCs transplanted and more apoptotic cells in 10(7) MSCs transplanted discs. The results of this study demonstrate that the number of cells transplanted affects the regenerative capability of MSC transplants in experimentally induced degenerating canine discs. It is suggested that maintenance of extracellular matrix by its production from transplanted cells and/or resident cells is important for checking the progression of structural disruption that leads to disc degeneration. Published by Wiley Periodicals, Inc. J Orthop Res 28:1267-1275, 2010.

Entities:  

Mesh:

Year:  2010        PMID: 20839317     DOI: 10.1002/jor.21147

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  55 in total

Review 1.  What is the clinical evidence on regenerative medicine in intervertebral disc degeneration?

Authors:  M Basso; L Cavagnaro; A Zanirato; S Divano; C Formica; M Formica; L Felli
Journal:  Musculoskelet Surg       Date:  2017-02-13

Review 2.  Stem cell therapy for intervertebral disc regeneration: obstacles and solutions.

Authors:  Daisuke Sakai; Gunnar B J Andersson
Journal:  Nat Rev Rheumatol       Date:  2015-02-24       Impact factor: 20.543

Review 3.  Stem cells sources for intervertebral disc regeneration.

Authors:  Gianluca Vadalà; Fabrizio Russo; Luca Ambrosio; Mattia Loppini; Vincenzo Denaro
Journal:  World J Stem Cells       Date:  2016-05-26       Impact factor: 5.326

Review 4.  The role of stem cell therapies in degenerative lumbar spine disease: a review.

Authors:  David Oehme; Tony Goldschlager; Jeffrey V Rosenfeld; Peter Ghosh; Graham Jenkin
Journal:  Neurosurg Rev       Date:  2015-03-07       Impact factor: 3.042

Review 5.  Cell therapy for the degenerating intervertebral disc.

Authors:  Wei Tong; Zhouyu Lu; Ling Qin; Robert L Mauck; Harvey E Smith; Lachlan J Smith; Neil R Malhotra; Martin F Heyworth; Franklin Caldera; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Transl Res       Date:  2016-11-28       Impact factor: 7.012

Review 6.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

7.  Composition of elastin like polypeptide-collagen composite scaffold influences in vitro osteogenic activity of human adipose derived stem cells.

Authors:  Bhuvaneswari Gurumurthy; Patrick C Bierdeman; Amol V Janorkar
Journal:  Dent Mater       Date:  2016-08-11       Impact factor: 5.304

8.  Disc cell therapy with bone-marrow-derived autologous mesenchymal stromal cells in a large porcine disc degeneration model.

Authors:  G W Omlor; S Lorenz; A G Nerlich; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2018-08-23       Impact factor: 3.134

9.  Human umbilical cord blood-derived mesenchymal stem cells in the cultured rabbit intervertebral disc: a novel cell source for disc repair.

Authors:  D Greg Anderson; Dessislava Markova; Howard S An; Ana Chee; Motomi Enomoto-Iwamoto; Vladimir Markov; Biagio Saitta; Peng Shi; Chander Gupta; Yejia Zhang
Journal:  Am J Phys Med Rehabil       Date:  2013-05       Impact factor: 2.159

Review 10.  A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics.

Authors:  Rita Lok-Hay Yim; Juliana Tsz-Yan Lee; Cora H Bow; Björn Meij; Victor Leung; Kenneth M C Cheung; Patrick Vavken; Dino Samartzis
Journal:  Stem Cells Dev       Date:  2014-09-11       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.